SEARCH

SEARCH BY CITATION

References

  • 1
    Lam SP, Luk JM, Man K, Ng KT, Cheung CK, Rose-John S & Lo CM (2010) Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration. Liver Transpl 16, 11951206.
  • 2
    Qiu Z, Sweeney DD, Netzeband JG & Gruol DL (1998) Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 18, 1044510456.
  • 3
    Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G & Kopf M (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561563.
  • 4
    Rodriguez Mdel C, Bernad A & Aracil M (2004) Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood 103, 33493354.
  • 5
    Mollmann H, Nef HM & Troidl C (2010) ‘Turning the right screw’: targeting the interleukin-6 receptor to reduce unfavourable tissue remodelling after myocardial infarction. Cardiovasc Res 87, 395396.
  • 6
    De Jongh RF, Vissers KC, Meert TF, Booij LH, De Deyne CS & Heylen RJ (2003) The role of interleukin-6 in nociception and pain. Anesth Analg 96, 10961103.
  • 7
    Weissenberger J, Loeffler S, Kappeler A, Kopf M, Lukes A, Afanasieva TA, Aguzzi A & Weis J (2004) IL-6 is required for glioma development in a mouse model. Oncogene 23, 33083316.
  • 8
    Sasaki A, Ishiuchi S, Kanda T, Hasegawa M & Nakazato Y (2001) Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines. Brain Tumor Pathol 18, 1321.
  • 9
    Waldner MJ, Foersch S & Neurath MF (2012) Interleukin-6 – a key regulator of colorectal cancer development. Int J Biol Sci 8, 12481253.
  • 10
    Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN & Hsieh CY (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22, 15171527.
  • 11
    Li R, Li G, Deng L, Liu Q, Dai J, Shen J & Zhang J (2010) IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol Rep 23, 15531559.
  • 12
    Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C & Zhang J (2010) IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol 100, 165176.
  • 13
    Chang CY, Li MC, Liao SL, Huang YL, Shen CC & Pan HC (2005) Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 12, 930933.
  • 14
    Prajapati SC & Chauhan SS (2011) Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter. FEBS J 278, 32563276.
  • 15
    Simaga S, Babic D, Osmak M, Sprem M & Abramic M (2003) Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas. Gynecol Oncol 91, 194200.
  • 16
    Shukla AA, Jain M & Chauhan SS (2010) Ets-1/Elk-1 is a critical mediator of dipeptidyl-peptidase III transcription in human glioblastoma cells. FEBS J 277, 18611875.
  • 17
    Van Meir E, Sawamura Y, Diserens AC, Hamou MF & de Tribolet N (1990) Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 50, 66836688.
  • 18
    Wang H, Lathia JD, Wu Q, Wang J, Li Z, Heddleston JM, Eyler CE, Elderbroom J, Gallagher J, Schuschu J et al. (2009) Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. Stem Cells 27, 23932404.
  • 19
    Loeffler S, Fayard B, Weis J & Weissenberger J (2005) Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115, 202213.
  • 20
    Saidi A, Hagedorn M, Allain N, Verpelli C, Sala C, Bello L, Bikfalvi A & Javerzat S (2009) Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer 125, 10541064.
  • 21
    Yamaguchi T, Naruishi K, Arai H, Nishimura F & Takashiba S (2008) IL-6/sIL-6R enhances cathepsin B and L production via caveolin-1-mediated JNK-AP-1 pathway in human gingival fibroblasts. J Cell Physiol 217, 423432.
  • 22
    Tsui KH, Wang SW, Chung LC, Feng TH, Lee TY, Chang PL & Juang HH (2013) Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells. Biomed Res Int 2013, 791212, doi: 10.1155/2013/791212
  • 23
    Mohamed MM, Cavallo-Medved D, Rudy D, Anbalagan A, Moin K & Sloane BF (2010) Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytes. Cell Physiol Biochem 25, 315324.
  • 24
    Margulies L & Sehgal PB (1993) Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBP beta (NF-IL6) activity by p53 species. J Biol Chem 268, 1509615100.
  • 25
    Huang Y, Shinzawa H, Togashi H, Takahashi T, Kuzumaki T, Otsu K & Ishikawa K (1995) Interleukin-6 down-regulates expressions of the aldolase B and albumin genes through a pathway involving the activation of tyrosine kinase. Arch Biochem Biophys 320, 203209.
  • 26
    Poree B, Kypriotou M, Chadjichristos C, Beauchef G, Renard E, Legendre F, Melin M, Gueret S, Hartmann DJ, Mallein-Gerin F et al. (2008) Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem 283, 48504865.
  • 27
    Pascussi JM, Gerbal-Chaloin S, Pichard-Garcia L, Daujat M, Fabre JM, Maurel P & Vilarem MJ (2000) Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 274, 707713.
  • 28
    Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T & Heinrich PC (1988) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232, 347350.
  • 29
    Andus T, Geiger T, Hirano T, Kishimoto T, Tran-Thi TA, Decker K & Heinrich PC (1988) Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures. Eur J Biochem 173, 287293.
  • 30
    Aigueperse C, Val P, Pacot C, Darne C, Lalli E, Sassone-Corsi P, Veyssiere G, Jean C & Martinez A (2001) SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells. Mol Endocrinol 15, 93111.
  • 31
    Buck M, Zhang L, Halasz NA, Hunter T & Chojkier M (2001) Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha. EMBO J 20, 67126723.
  • 32
    Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H et al. (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318325.
  • 33
    Dentesano G, Straccia M, Ejarque-Ortiz A, Tusell JM, Serratosa J, Saura J & Sola C (2012) Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells. J Neuroinflammation 9, 165.
  • 34
    Fields J & Ghorpade A (2012) C/EBP beta regulates multiple IL-1beta-induced human astrocyte inflammatory genes. J Neuroinflammation 9, 177.
  • 35
    Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, Manns MP & Trautwein C (2004) C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 40, 356365.
  • 36
    Smink JJ, Begay V, Schoenmaker T, Sterneck E, de Vries TJ & Leutz A (2009) Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB. EMBO J 28, 17691781.
  • 37
    Trautwein C, Rakemann T, Pietrangelo A, Plumpe J, Montosi G & Manns MP (1996) C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration. J Biol Chem 271, 2226222270.
  • 38
    Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T & Kishimoto T (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9, 18971906.
  • 39
    Homma J, Yamanaka R, Yajima N, Tsuchiya N, Genkai N, Sano M & Tanaka R (2006) Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncol Rep 15, 595601.
  • 40
    Ramji DP, Vitelli A, Tronche F, Cortese R & Ciliberto G (1993) The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. Nucleic Acids Res 21, 289294.
  • 41
    Niehof M, Streetz K, Rakemann T, Bischoff SC, Manns MP, Horn F & Trautwein C (2001) Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. J Biol Chem 276, 90169027.
  • 42
    Chen GK, Sale S, Tan T, Ermoian RP & Sikic BI (2004) CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Mol Pharmacol 65, 906916.
  • 43
    Oya M, Horiguchi A, Mizuno R, Marumo K & Murai M (2003) Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma. Clin Cancer Res 9, 10211027.
  • 44
    Mir RA & Chauhan SS (2011) Down regulation of a matrix degrading cysteine protease cathepsin L, by acetaldehyde: role of C/EBPalpha. PLoS ONE 6, e20768.
  • 45
    Bezerra GA, Dobrovetsky E, Viertlmayr R, Dong A, Binter A, Abramic M, Macheroux P, Dhe-Paganon S & Gruber K (2012) Entropy-driven binding of opioid peptides induces a large domain motion in human dipeptidyl peptidase III. Proc Natl Acad Sci U S A 109, 65256530.
  • 46
    Barsun M, Jajcanin N, Vukelic B, Spoljaric J & Abramic M (2007) Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins. Biol Chem 388, 343348.
  • 47
    Sato H, Kimura K, Yamamoto Y & Hazato T (2003) Activity of DPP III in human cerebrospinal fluid derived from patients with pain. Masui 52, 257263.
  • 48
    Tchirkov A, Khalil T, Chautard E, Mokhtari K, Veronese L, Irthum B, Vago P, Kemeny JL & Verrelle P (2007) Interleukin-6 gene amplification and shortened survival in glioblastoma patients. Br J Cancer 96, 474476.
  • 49
    Rodriguez-Antona C, Bort R, Jover R, Tindberg N, Ingelman-Sundberg M, Gomez-Lechon MJ & Castell JV (2003) Transcriptional regulation of human CYP3A4 basal expression by CCAAT enhancer-binding protein alpha and hepatocyte nuclear factor-3 gamma. Mol Pharmacol 63, 11801189.